However, continuous treatment with ALCAR may lead to mitochondrial storage which could explain why there is no significant difference between pre and post dose levels in most treatment groups
14, 2005 BioWorld Science Endocrine/metabolic
One is that GLP-1 medications slow down the movement of your GI tract
Fibroblast and collagen endpoints include: fibroblast outgrowth fibroblast migration collagen production markers collagen fibre organisation growth hormone receptor expression extracellular matrix marker changes tendon fibroblast activity This makes BPC-157 Research Peptide especially relevant to tendon, ligament and extracellular matrix research
Researchers from Brigham and Womens Hospital and Harvard Medical School found that these drugs are associated with increased risks of gastroparesis (stomach paralysis), bowel obstruction, and pancreatitis
"Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload." Journal of Anatomy, 194(3), 323-334
